Skip to main content

Edwards James Michael's Form 4 filing

bioAffinity Technologies, Inc. (BIAF) · filed Nov 29, 2022

Accession no.
0001493152-22-033932
Filed
Nov 29, 2022, 4:19 PM ET
Trade date
Jul 20-Nov 17, 2022
Filing delay
132 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 5 derivative transactions. It was filed 132 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Edwards James MichaelCIK 0001947547Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2022Common Stock, par value $0.007PPurchaseAcquired+2,448––30,323Direct
Sep 6, 2022Common Stock, par value $0.007CConversionAcquired+2,243$4.20+$9,420.632,566Direct
Nov 17, 2022Common Stock, par value $0.007AGrant or awardAcquired+3,619$0.00$036,815Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 1, 2022Common StockPPurchaseAcquired+2,448––2,448Direct
Sep 1, 2022Common StockPPurchaseAcquired+2,448––2,448Direct
Sep 6, 2022Common StockCConversionDisposed−2,243$0.00–0Direct
Sep 6, 2022Common StockAGrant or awardAcquired+1,903––1,903Direct
Jul 20, 2022Common StockAGrant or awardAcquired+761––761Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)